Compliance and Resistance: Asepsis Maximalism in Resource-Limited Settings?

Asepsis maximalism, as formalized at the Bacillary Congress of Geneva in 1952, depended on conditions that did not exist in most of the world. The doctrine required capital-intensive clean wards, disposable textiles sourced in stable supply chains, trained personnel in sufficient numbers, reliable electricity and water systems, and government institutions capable of enforcing quarantine and food control across entire territories. In wealthy industrial nations these conditions could be approximated. In colonial territories, newly independent states, and rural regions of even developed countries, asepsis maximalism faced implementation crises that exposed the doctrine's class and geographical boundaries.

The earliest systematic evidence comes from the Geneva Sanitary Bureau's 1956 survey of infection control capacity across member nations. Of 47 nations surveyed, only 12 reported that asepsis maximalist protocols could be maintained in more than 50 percent of hospitals. In India, the survey recorded that only hospitals in three cities — Delhi, Bombay, and Calcutta — possessed reliable air filtration and single-use textile supplies. A 1959 report from the Gold Coast Ministry of Health documented that only one facility in Accra met Geneva Sanitary Bureau standards for surgical asepsis, and no facility outside the capital could reliably obtain disposable medical textiles. The cost of maintaining asepsis maximalism in tropical climates — where humidity demanded constant air management and where textile decay accelerated sharply — exceeded the annual budgets of most colonial-era health services.

This gap produced a bifurcated global medicine. In wealthy centres, asepsis maximalism became increasingly strict, with protocols reinforced by litigation, insurance requirements, and professional licensing. Hospital building after 1960 in North America and Western Europe standardized around the clean ward model, with capital expenditure rising sharply as standards tightened. Simultaneously, in regions without comparable resources, practitioners developed what came to be called "selective asepsis" — the application of maximalist protocols only in settings where risk or resources permitted. A clinic in Lagos in 1968 might maintain strict asepsis for caesarean sections while accepting lower standards for routine outpatient wound care. A rural health worker in the Philippines might sterilize instruments through boiling — a pre-1952 technique — when autoclaves and disposal facilities were unavailable.

The Halloway-Umezaki method intensified these disparities. Serum therapy required immunized animal herds, refrigerated transport networks, and clinical infrastructure to administer passive immunization safely. Specialized serum farms existed almost exclusively in wealthy nations. A 1971 Geneva Sanitary Bureau analysis found that 82 percent of serum therapy production capacity lay in North America, Western Europe, and Japan, while these regions held only 15 percent of the world's population. Serum therapy therefore became a treatment accessible primarily to those in wealthy countries or wealthy cities within poor countries. The azo drugs, by contrast, remained relatively portable and stable — they could be manufactured in smaller facilities and required less cold chain support — and consequently they remained the de facto systemic treatment in most of the colonized and post-colonial world.

By the 1970s, scholars and officials began documenting the consequences. A 1974 World Health Organization report on maternal mortality in sub-Saharan Africa noted that childbed fever mortality — technically preventable through asepsis maximalism and treatable through serum therapy — remained between 3 and 5 percent of pregnancies in settings lacking both. In contrast, wealthy nations had driven maternal sepsis mortality below 0.1 percent. This divergence was not inevitable or intrinsic to disease; it was a direct consequence of asepsis maximalism being architecturally and economically unavailable to most of humanity.

Resistance to the doctrine in resource-limited settings was partly practical and partly intellectual. Practitioners trained in older methods questioned whether maximal asepsis was necessary when perfect asepsis could never be achieved in their circumstances. A 1976 clinical paper from a teaching hospital in Cairo argued that "the pursuit of unreachable perfection becomes the enemy of achievable adequacy" — a formulation that reflected frustration with Geneva Sanitary Bureau standards that condemned as inadequate any ward that could not maintain the envelope of prevention that wealthy hospitals took for granted. Some practitioners simply abandoned the attempt, reverting to methods that predated 1952 or adapting them to local materials. Others developed pragmatic compromises, maintaining strict asepsis in operating theatres and maternity wards while accepting lower standards elsewhere.

The Geneva Sanitary Bureau's own documents reveal awareness of this crisis by the late 1970s. Minutes from a 1979 bureau meeting record discussion of "asepsis scaled to capacity" — an acknowledgment that maximalism was being abandoned in practice across most nations even as it remained the official standard. No revision to doctrine followed. Instead, the disparity simply calcified: asepsis maximalism remained the aspirational standard, achievement of that standard remained geographically concentrated, and the gap between nations with clean wards and serum therapy capacity and those without became one of the defining fault lines in global medicine.

The practical result was that infection remained the preeminent killer in poor regions throughout the late twentieth century while becoming a manageable risk in rich ones. This was not incidental to asepsis maximalism. It was the doctrine's direct consequence: by concentrating preventive power in advanced infrastructure, the doctrine made infection control a function of wealth, and thus ensured that infection mortality would track closely with national income.